1. Medtech Insight
  2. >>Geography
  3. >>Europe

How To Jump Aboard The New EU Innovative Health Initiative Train And Where It Is Heading

 
• By Amanda Maxwell

For MedTech Europe’s Patrick Boisseau, the newly launched Innovative Health Initiative is a real “game changer.” In this interview, he explains how companies should get involved in cross-sectoral medtech/pharma projects that will revolutionize European healthcare innovation.

Idea exchange concept. Ideas agreement Investing in business innovation and financial commerce backing of creativity. Open lightbulb icon with gear mechanisms. Funding potential innovative growth - Image

Patrick Boisseau, director general industry strategic initiativesat industry association, MedTech Europe, spends 80% of his time working as the representative of MedTech Europe on the governing board of the EU’s Innovative Health Initiative, part of the Horizon Europe program. He believes the project will have a “major impact” on future healthcare delivery through the convergence of innovation in medtech and pharma on a scale never seen before.

Through cross-sectoral initiatives, the IHI aims to create “really new ideas, new contexts, new products and new solutions for patients” through pre-competitive research, the results of which will benefit us all as patients, Boisseau told Medtech Insight during a recent

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By Ashley Yeo

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.

More from Geography